Researchers from the University of Turin published the results of a prospective, randomized, and controlled trial evaluating the use of L-carnitine and selenium when combined with standard therapy for Graves’ disease, an autoimmune disorder that affects the thyroid gland. This study follows a previously published pilot study, which found that 500 mg of L-carnitine in combination with 83 mcg selenium (as selenomethionine) taken daily for one month could improve quality of life and symptoms a...
